Exclusive: RBC Analyst Weighs in on Icahn's Proxy Battle for Illumina

Conor McNamara, CFA, an equity research analyst with RBC Capital Markets, discusses Icahn’s proxy battle against Illumina, and the company’s strengths and challenges, with GEN Edge.

Related Keywords

United States ,D Michael Chappell ,Carl Icahn ,Conor Mcnamara ,Oxford Nanopore ,European Commission ,Us Federal Trade Commission ,European Union ,Trade Commission ,Chief Administrative Law Judge ,Icahn Partners ,Singular Genomics ,Innovation Roadmap ,Illumina Genomics Forum ,